Evidence map›Paper›PMID 35763079›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2022

Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis?

L De Simone, M Bonacini, R Aldigeri, F Alessandrello, V Mastrofilippo, F Gozzi, E Bolletta, C Adani, A Zerbini, G M Cavallini and 4 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Sarcoidosis-Related Uveitis: A Review.Journal of clinical medicine · 2023
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

L De Simone *Ocular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
M Bonacini *Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
R AldigeriDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
F AlessandrelloDepartment of Biomedical Sciences, Ophthalmology Clinic, University Hospital of Messina, Messina, Italy.
V MastrofilippoOcular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
F GozziOcular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
E BollettaOcular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
C AdaniOcular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
A ZerbiniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
G M CavalliniOcular Immunology Unit, Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Azienda USL-IRCCS Di Reggio Emilia, 42121, Reggio Emilia, Modena, Italy.
L FontanaOphthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna and S.Orsola-Malpighi Teaching Hospital, Bologna, Italy.
C SalvaraniOcular Immunology Unit, Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Azienda USL-IRCCS Di Reggio Emilia, 42121, Reggio Emilia, Modena, Italy.
S Croci *Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
L Cimino *Ocular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy. cimino.luca@ausl.re.it.ORCID http://orcid.org/0000-0001-7956-9950
Istituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Modena and Reggio Emilia · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITUniversity of Messina · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVE AND

designA cross-sectional single-center study was conducted to assess cytokine levels in aqueous humor (AH) and plasma of three different uveitis entities: definite ocular sarcoidosis (OS), definite OS associated with QuantiFERON®-TB Gold test positivity (Q + OS) and presumed tubercular uveitis (TBU). SUBJECTS: Thirty-two patients (15 OS, 5 Q + OS, 12 TBU) were included.

methodsQuantification of selected cytokines was performed on blood and AH samples collected before starting any treatment. Statistical analysis was conducted using the Kruskal-Wallis test, the Mann-Whitney or Fisher test and the Principal Component Analysis (PCA).

resultsIL-6, IL-8 and IP-10 levels were higher in AH samples than in peripheral blood. In AH samples, BLC, IL-8 and IP-10 were significantly higher in definite OS than in presumptive TBU. There were no statistically significant differences in terms of cytokine levels between Q + OS and presumptive TBU. PCA showed a similar cytokine pattern in the latter two groups (IFNγ, IL-15, IL-2, IP-10, MIG), while the prevalent expression of BLC, IL-10 and MIP-3 α was seen in definite OS.

conclusionsThe different AH and plasma cytokine profiles observed in OS compared to Q + OS and TBU may help to differentiate OS from TBU in overlapping clinical phenotypes of granulomatous uveitis (Q + OS).

Indexed as

SarcoidosisTuberculosis, OcularUveitisAqueous HumorChemokine CXCL10Cross-Sectional StudiesCytokinesHumansInterleukin-8Chemokine CXCL10CytokinesInterleukin-8Aqueous humorCytokinesSarcoidosisTuberculosisUveitis

Identifiers

PMID35763079
OpenAlexW4283658053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.